https://research.regionh.dk/da/publications/effect-of-secukinumab-versus-adalimumab-biosimilar-on-radiographi/
Effect of Secukinumab versus Adalimumab Biosimilar on Radiographic Progression in Patients with...
adalimumab biosimilareffectsecukinumabversusradiographic
https://www.centerforbiosimilars.com/view/review-real-world-evidence-confirms-effectiveness-and-safety-of-adalimumab-biosimilar-sb5
Review: Real-World Evidence Confirms Effectiveness and Safety of Adalimumab Biosimilar SB5
The adalimumab biosimilar SB5 was reported to be as safe and effective as the reference product in a review of randomized controlled trials and real-world...
real world evidenceadalimumab biosimilarreviewconfirmseffectiveness
https://www.biosimilarsip.com/2018/04/20/fujifilm-and-mylan-announce-partnership-to-commercialize-adalimumab-biosimilar/
Fujifilm and Mylan Announce Partnership to Commercialize Adalimumab Biosimilar | Biosimilars Law...
Sep 10, 2020 - Fujifilm Kyowa Kirin Biologics Co., Ltd. (“Fujifilm”) recently announced that it will partner with Mylan N.V. (“Mylan”) to commercialize a biosimilar to
adalimumab biosimilarfujifilmmylanannouncepartnership
https://www.centerforbiosimilars.com/view/fresenius-kabi-gains-european-authorization-to-market-adalimumab-biosimilar-idacio
Fresenius Kabi Gains European Authorization to Market Adalimumab Biosimilar, Idacio
Fresenius Kabi announced today that it has received its first European marketing authorization for a biosimilar. The European Commission granted the drug...
fresenius kabiadalimumab biosimilargainseuropeanauthorization
https://raportuldegarda.ro/fda-aproba-cyltezo-biosimilarul-interschimbabil-adalimumab-boli-inflamatorii/
FDA aprobă Cyltezo, primul anticorp monoclonal biosimilar interschimbabil cu adalimumab, pentru...
Food and Drug Administration (FDA) a aprobat Cyltezo (adalimumab-adbm), primul produs biosimilar interschimbabil cu adalimumab. Cyltezo este atât biosimilar,...
fdacyltezoprimulanticorpmonoclonal